Where April 2025 Digital Health Capital Actually Went
April 2025's biggest digital-health cheques went to diagnostics, metabolic hardware, care-operations software, and fertility infrastructure. Where value compounds next.
Read More
The GLP-1 Endgame: Value Is Migrating Off the Molecule
Lilly catches Novo, Ypsomed sells diabetes care, Virta cuts GLP-1 use, WeightWatchers files Chapter 11. Where the next decade of obesity-care value sits.
Read More
Seed to Series A Slowdown Across Borders
Seed-to-Series A conversion rates are plummeting across geographies and sectors. Allegory Capital breaks down why startups are stalling and what this means for VCs and founders navigating the post-seed desert in 2024.
Read More